R848: Clinical Trials

3 trials of R848, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Active not recruiting 1, Completed 1, Recruiting 1

Follow R848: new trials by email Literature Review of R848 trials Research Report on R848

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
R848, Saline - Innate Immunity, Mucosal Immunity
Not applicableRecruitingAkhilesh Jha362024-05-242026-11-03
Nasal Immune Challenge Study
R848, Saline - Innate Inflammatory Response, Asthma
Not applicableActive not recruitingCambridge University Hospitals NHS Foundation Trust242022-08-092026-11-03
Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen
Poly ICLC, Poly I:C, R848 - Allergic Rhinitis, Asthma
Not applicableCompletedImperial College London932014-03-012021-11-05

Conditions studied

Asthma (3)  ·  Inflammation (2)  ·  Virus Diseases (2)  ·  Hypersensitivity (1)  ·  Latent Tuberculosis (1)  ·  Respiratory Tract Infections (1)  ·  Rhinitis, Allergic (1)  ·  Rhinitis, Allergic, Seasonal (1)  ·  Tuberculosis (1)

Sponsors

Akhilesh Jha (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Imperial College London (1)

Countries

United Kingdom (3)

Top investigators

Peter JM Openshaw, FRCP, PhD, FRSB, FMedSci (1)  ·  Robin Shattock, PhD (1)  ·  Trevor Hansel, FRCPath, PhD (1)